Evaluation of tumor-infiltrating lymphocytes and mammographic density as predictors of response to neoadjuvant systemic therapy in breast cancer

被引:0
作者
Landen, Amalia H. [1 ,5 ]
Chin, Kian [2 ]
Kovacs, Aniko [3 ]
Holmberg, Erik [1 ]
Molnar, Eva [4 ]
Tullberg, Axel Stenmark [1 ]
Warnberg, Fredrik [2 ]
Karlsson, Per [1 ]
机构
[1] Univ Gothenburg, Inst Clin Sci, Sahlgrenska Acad, Dept Oncol, Gothenburg, Sweden
[2] Univ Gothenburg, Inst Clin Sci, Sahlgrenska Acad, Dept Surg, Gothenburg, Sweden
[3] Sahlgrens Univ Hosp, Dept Clin Pathol, Gothenburg, Sweden
[4] Sahlgrens Univ Hosp, Dept Radiol, Gothenburg, Sweden
[5] Sahlgrens Univ Hosp, Dept Oncol, Bla Straket 2,4th Floor, S-41345 Gothenburg, Sweden
关键词
Breast cancer; tumor-infiltrating lymphocytes; mammographic density; neoadjuvant therapy; pathological complete response; INTERNATIONAL EXPERT CONSENSUS; HISTOLOGICAL GRADE; CHEMOTHERAPY; ASSOCIATION; RISK; SURVIVAL; SUBTYPES; WOMEN;
D O I
10.1080/0284186X.2023.2274483
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Response rates vary among breast cancer patients treated with neoadjuvant systemic therapy (NAST). Thus, there is a need for reliable treatment predictors. Evidence suggests tumor-infiltrating lymphocytes (TILs) predict NAST response. Still, TILs are seldom used clinically as a treatment determinant. Mammographic density (MD) is another potential marker for NAST benefit and its relationship with TILs is unknown. Our aims were to investigate TILs and MD as predictors of NAST response and to study the unexplored relationship between TILs and MD.Material and methods: We studied 315 invasive breast carcinomas treated with NAST between 2013 and 2020. Clinicopathological data were retrieved from medical records. The endpoint was defined as pathological complete response (pCR) in the breast. TILs were evaluated in pre-treatment core biopsies and categorized as high (>= 10%) or low (<10%). MD was scored (a-d) according to the breast imaging reporting and data system (BI-RADS) fifth edition. Binary logistic regression and Spearman's test of correlation were performed using SPSS.Results: Out of 315 carcinomas, 136 achieved pCR. 94 carcinomas had high TILs and 215 had low TILs. Six carcinomas had no available TIL data. The number of carcinomas in each BI-RADS category were 37, 122, 112, and 44 for a, b, c, and d, respectively. High TILs were independently associated with pCR (OR: 2.95; 95% CI: 1.59-5.46) compared to low TILs. In the univariable analysis, MD (BI-RADS d vs. a) showed a tendency of higher likelihood for pCR (OR: 2.43; 95% CI: 0.99-5.98). However, the association was non-significant, which is consistent with the result of the multivariable analysis (OR: 2.51; 95% CI: 0.78-8.04). We found no correlation between TILs and MD (0.02; p = .80).Conclusion: TILs significantly predicted NAST response. We could not define MD as a significant predictor of NAST response. These findings should be further replicated.
引用
收藏
页码:1862 / 1872
页数:11
相关论文
共 53 条
  • [1] Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
    Alberro, J. A.
    Ballester, B.
    Deulofeu, P.
    Fabregas, R.
    Fraile, M.
    Gubern, J. M.
    Janer, J.
    Moral, A.
    de Pablo, J. L.
    Penalva, G.
    Puig, P.
    Ramos, M.
    Rojo, R.
    Santesteban, P.
    Serra, C.
    Sola, M.
    Solarnau, L.
    Solsona, J.
    Veloso, E.
    Vidal, S.
    Abe, O.
    Abe, R.
    Enomoto, K.
    Kikuchi, K.
    Koyama, H.
    Masuda, H.
    Nomura, Y.
    Ohashi, Y.
    Sakai, K.
    Sugimachi, K.
    Toi, M.
    Tominaga, T.
    Uchino, J.
    Yoshida, M.
    Coles, C. E.
    Haybittle, J. L.
    Moebus, V.
    Leonard, C. F.
    Calais, G.
    Garaud, P.
    Collett, V.
    Davies, C.
    Delmestri, A.
    Sayer, J.
    Harvey, V. J.
    Holdaway, I. M.
    Kay, R. G.
    Mason, B. H.
    Forbe, J. F.
    Franci, P. A.
    [J]. LANCET ONCOLOGY, 2018, 19 (01) : 27 - 39
  • [2] Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group
    Amgad, Mohamed
    Stovgaard, Elisabeth Specht
    Balslev, Eva
    Thagaard, Jeppe
    Chen, Weijie
    Dudgeon, Sarah
    Sharma, Ashish
    Kerner, Jennifer K.
    Denkert, Carsten
    Yuan, Yinyin
    AbdulJabbar, Khalid
    Wienert, Stephan
    Savas, Peter
    Voorwerk, Leonie
    Beck, Andrew H.
    Madabhushi, Anant
    Hartman, Johan
    Sebastian, Manu M.
    Horlings, Hugo M.
    Hudecek, Jan
    Ciompi, Francesco
    Moore, David A.
    Singh, Rajendra
    Roblin, Elvire
    Balancin, Marcelo Luiz
    Mathieu, Marie-Christine
    Lennerz, Jochen K.
    Kirtani, Pawan
    Chen, I-Chun
    Braybrooke, Jeremy P.
    Pruneri, Giancarlo
    Demaria, Sandra
    Adams, Sylvia
    Schnitt, Stuart J.
    Lakhani, Sunil R.
    Rojo, Federico
    Comerma, Laura
    Badve, Sunil S.
    Khojasteh, Mehrnoush
    Symmans, W. Fraser
    Sotiriou, Christos
    Gonzalez-Ericsson, Paula
    Pogue-Geile, Katherine L.
    Kim, Rim S.
    Rimm, David L.
    Viale, Giuseppe
    Hewitt, Stephen M.
    Bartlett, John M. S.
    Penault-Llorca, Frederique
    Goel, Shom
    [J]. NPJ BREAST CANCER, 2020, 6 (01)
  • [3] Heritability of mammographic density, a risk factor for breast cancer
    Boyd, NF
    Dite, GS
    Stone, J
    Gunasekara, A
    English, DR
    McCredie, MRE
    Giles, GG
    Tritchler, D
    Chiarelli, A
    Yaffe, MJ
    Hopper, JL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (12) : 886 - 894
  • [4] The association of breast mitogens with mammographic densities
    Boyd, NF
    Stone, J
    Martin, LJ
    Jong, R
    Fishel, E
    Yaffe, M
    Hammond, G
    Minkin, S
    [J]. BRITISH JOURNAL OF CANCER, 2002, 87 (08) : 876 - 882
  • [5] Mammographic density and breast cancer risk: current understanding and future prospects
    Boyd, Norman F.
    Martin, Lisa J.
    Yaffe, Martin J.
    Minkin, Salomon
    [J]. BREAST CANCER RESEARCH, 2011, 13 (06)
  • [6] BI-RADS Ultrasound Lexicon Descriptors and Stromal Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
    Candelaria, Rosalind P.
    Spak, David A.
    Rauch, Gaiane M.
    Huo, Lei
    Bassett, Roland L.
    Santiago, Lumarie
    Scoggins, Marion E.
    Guirguis, Mary S.
    Patel, Miral M.
    Whitman, Gary J.
    Moulder, Stacy L.
    Thompson, Alastair M.
    Ravenberg, Elizabeth E.
    White, Jason B.
    Abuhadra, Nour K.
    Valero, Vicente
    Litton, Jennifer
    Adrada, Beatriz E.
    Yang, Wei T.
    [J]. ACADEMIC RADIOLOGY, 2022, 29 : S35 - S41
  • [7] Castaneda Carlos A, 2014, Hematol Oncol Stem Cell Ther, V7, P149, DOI 10.1016/j.hemonc.2014.09.001
  • [8] Comparison of tumor-infiltrating lymphocytes of breast cancer in core needle biopsies and resected specimens: a retrospective analysis
    Cha, Yoon Jin
    Ahn, Sung Gwe
    Bae, Soong June
    Yoon, Chang Ik
    Seo, Jayeong
    Jung, Woo Hee
    Son, Eun Ju
    Jeong, Joon
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2018, 171 (02) : 295 - 302
  • [9] The association between breast density and breast cancer pathological response to neoadjuvant chemotherapy
    Cullinane, C.
    Brien, A. O.
    Shrestha, A.
    Hanlon, E. O.
    Walshe, J.
    Geraghty, J.
    Evoy, D.
    McCartan, D.
    McDermott, E.
    Prichard, R.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2022, 194 (02) : 385 - 392
  • [10] De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
    Curigliano, G.
    Burstein, H. J.
    Winer, E. P.
    Gnant, M.
    Dubsky, P.
    Loibl, S.
    Colleoni, M.
    Regan, M. M.
    Piccart-Gebhart, M.
    Senn, H. -J.
    Thurlimann, B.
    Andre, F.
    Baselga, J.
    Bergh, J.
    Bonnefoi, H.
    Brucker, S. Y.
    Cardoso, F.
    Carey, L.
    Ciruelos, E.
    Cuzick, J.
    Denkert, C.
    Di Leo, A.
    Ejlertsen, B.
    Francis, P.
    Galimberti, V.
    Garber, J.
    Gulluoglu, B.
    Goodwin, P.
    Harbeck, N.
    Hayes, D. F.
    Huang, C. -S.
    Huober, J.
    Khaled, H.
    Jassem, J.
    Jiang, Z.
    Karlsson, P.
    Morrow, M.
    Orecchia, R.
    Osborne, K. C.
    Pagani, O.
    Partridge, A. H.
    Pritchard, K.
    Ro, J.
    Rutgers, E. J. T.
    Sedlmayer, F.
    Semiglazov, V.
    Shao, Z.
    Smith, I.
    Toi, M.
    Tutt, A.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 (08) : 1700 - 1712